Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isolagen Therapy in Restrictive Burn Scars
NCT00620737Phase 2Withdrawn
- Sponsor
- Castle Creek Biosciences
- Start
- Feb 2008
- Primary completion
- Dec 2008
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azficel-t in burn scar (2 arms), sponsored by Castle Creek Biosciences. Primary endpoint: Change from baseline of all study assessments at Day 120. Planned start Feb 2008; status: withdrawn.
02
Drugs
azficel-t
03
Conditions
burn scar
Beyond the preview
Go deeper on NCT00620737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620737.